Azerbaijan vs Germany: The number of people with susceptibility test result for rifampicin
Azerbaijan
1,409
in 2021
Germany
1,440
in 2021
Azerbaijan rank
59th
Germany rank
58th
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Germany
How they compare
Germany currently reports 1,440 against 1,409 in Azerbaijan, a difference of 31.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Azerbaijan ahead.
Azerbaijan ranks 59th and Germany ranks 58th of 155 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Germany in 1.
Head to head by decade
| Decade | Azerbaijan | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,956 | 1,298 | 657.67 | Azerbaijan |
| 2020s | 1,327 | 1,502 | 175.5 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Germany?
- Germany, at 1,440 against 1,409 in Azerbaijan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Germany?
- 31, with Germany ahead.
- How many years of comparable data are there for Azerbaijan and Germany?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Germany rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 59th and Germany ranks 58th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.